Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07318402 · ClinicalTrials.gov registry record
Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study
A clinical trial of Operator Radiation Exposure, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 350
- Enrollment target
- 1
- Study location
NCT07318402: Recruiting study of Operator Radiation Exposure, sponsored by Memorial Sloan Kettering Cancer Center.
NCT07318402 is a study of Operator Radiation Exposure that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 350 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07318402, a study of Operator Radiation Exposure, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 350 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a multicenter, single-arm, prospective, observational study designed to evaluate bronchoscopist radiation exposure during standard-of-care image-guided robotic-assisted bronchoscopy (RAB) for sampling of a single pulmonary parenchymal lesion.
Primary Outcome
as captured by a radiation dosimetry badge over 50 consecutive procedures. All study procedures in which image-guided RAB was performed for the sampling of a single parenchymal lung lesion will be evaluable for the primary endpoint.
Conditions Studied
Study Locations (1)
New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2025-12-23 |
| Est. Completion | 2028-12 |
What NCT07318402 shows while recruiting
NCT07318402 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Operator Radiation Exposure appearing as the primary indexed condition, and to 0 interventions.
NCT07318402 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07318402 about?
NCT07318402 is a clinical study titled "Operator Radiation Exposure During Image-Guided Robotic-Assisted Bronchoscopy: A Multicenter Prospective Cohort Study". This is a multicenter, single-arm, prospective, observational study designed to evaluate bronchoscopist radiation exposure during standard-of-care image-guided robotic-assisted bronchoscopy (RAB) for sampling of a single pulmonary parenchymal lesion.
What is the current status of trial NCT07318402?
This trial is currently recruiting. The enrollment target is 350 participants. The study started on 2025-12-23. Estimated completion is 2028-12.
What conditions does trial NCT07318402 study?
This clinical trial studies the following conditions: Operator Radiation Exposure.
Who is sponsoring clinical trial NCT07318402?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07318402 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI